Effect of intra-articular administration of interleukin 1 receptor antagonist on cartilage repair in temporomandibular joint

Journal of Craniofacial Surgery

Volumn 22, Issue 2, 2011, Pages 711-714

  Zhang, Bi ^a   Hu, Jing ^a   Man, Cheng ^a   Zhu, Songsong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

cartilage; Interleukin 1; interleukin 1 receptor antagonist; osteoarthritis; temporomandibular joint

Indexed keywords

AGGRECAN; AGGRECANASE; COLLAGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; DRUG EFFECT; INTRAARTICULAR DRUG ADMINISTRATION; MALE; METABOLISM; NONPARAMETRIC TEST; OSTEOARTHRITIS; PATHOLOGY; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPOROMANDIBULAR JOINT;

AGGRECANS; ANIMALS; COLLAGEN; ENDOPEPTIDASES; INJECTIONS, INTRA-ARTICULAR; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; OSTEOARTHRITIS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; TEMPOROMANDIBULAR JOINT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79953857423     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e31820873c6     Document Type: Article

References (20)

1. Cascone P, Fonzi Dagger L, Aboh IV. Hyaluronic acid's biomechanical stabilization function in the temporomandibular joint. J Craniofac Surg 2002;13:751-754 (Pubitemid 36764265)
2. Blaney Davidson EN, van der Kraan PM, van den Berg WB. TGF-beta and osteoarthritis. Osteoarthr Cartil 2007;15:597-604
3. Emshoff R, Rudisch A. Temporomandibular joint internal derangement and osteoarthrosis: are effusion and bone marrow edema prognostic indicators for arthrocentesis and hydraulic distention? J Oral Maxillofac Surg 2007;65:66-73
4. Leonardi R, Michelotti A, Farella M, et al. Fibronectin upregulation in human temporomandibular joint disks with internal derangement. J Craniofac Surg 2004;15:678-683
5. Kubota E, Imamura H, Kubota T, et al. Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 1997;55:20-27
6. Kubota E, Kubota T, Matsumoto J, et al. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 1998;56:192-198 (Pubitemid 28100580)
7. Abramson SB, Amin A. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology 2002;41:972-980
8. Feige U, Hu YL, Gasser J, et al. Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats. Cell Mol Life Sci 2000;57:1457-1470
9. Mulcahy NJ, Ross J, Rothwell NJ, et al. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 2003;140:471-476 (Pubitemid 37330491)
10. Chevalier X, Goupille P, Beaulieu AD, et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009;61:344-352
11. Man C, Zhu S, Zhang B, et al. Protection of articular cartilage from degeneration by injection of transforming growth factor-beta in temporomandibular joint osteoarthritis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:335-340
12. Neo H, Ishimaru JI, Kurita K, et al. The effect of hyaluronic acid on experimental temporomandibular joint osteoarthritis in the sheep. J Oral Maxillofac Surg 1997;55:1114-1149
13. Baragi VM, Renkiewicz RR, Jordan H, et al. Transplantation of transduced chondrocytes protects articular cartilage from interleukin1-induced extracellular matrix degradation. J Clin Invest 1995;96:2454-2460
14. Caron JP, Fernandes JC, Martel-Pelletier J, et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: suppression of collagenase-1 expression. Arthritis Rheum 1996;39:1535-1544 (Pubitemid 26314988)
15. Pelletier JP, Caron JP, Evans C, et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 1997;40:1012-1019
16. Fernandes J, Tardif G, Martel-Pelletier J, et al. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. Am J Pathol 1999;154:1159-1169
17. Fang PK, Ma XC, Ma DL, et al. Determination of interleukin-1 receptor antagonist, interleukin-10, and transforming growth factor-β1 in synovial fluid aspirates of patients with temporomandibular disorders. J OralMaxillofac Surg 1999;57:922-928
18. Melissa A, Kacena Greg A, Merrel Sanjit R, et al. Inflammation and bony changes at the temporomandibular joint. Cells Tissues Organs 2001;169:257-264
19. Tominagaa K, Habua M, Sukedai M, et al. IL-1β, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders. Arch Oral Biol 2004;49:493-499
20. Urech DM, Feige U, Ewert S, et al. Anti-inflammatory and cartilage-protecting effects of an intra-articularly injected anti-TNF{alpha} single-chain Fv antibody (ESBA105) designed for local therapeutic use. Ann Rheum Dis 2010;69:443-449